A. Viacava Follis

Discovery of potent and selective reversible Bruton's tyrosine kinase inhibitors.

A. Bender, A. Goutopoulos, Xiaohua Zhu, 2021, Bioorganic & medicinal chemistry.

Identification and Characterization of an Allosteric Inhibitory Site on Dihydropteroate Synthase

D. Bashford, D. Hammoudeh, S. White, 2014, ACS chemical biology.

Discovery of Affinity‐Based Probes for Btk Occupancy Assays

Daigen Xu, A. Bender, A. Goutopoulos, 2019, ChemMedChem.

Optimization of the efflux ratio and permeability of covalent irreversible BTK inhibitors.

A. Goutopoulos, R. Grenningloh, A. Gardberg, 2018, Bioorganic & medicinal chemistry letters.

Discoveries and controversies in BCL‐2 protein‐mediated apoptosis

R. Kriwacki, T. Moldoveanu, A. Viacava Follis, 2016, The FEBS journal.

Discovery of novel covalent BTK inhibitors with reduced CYP2C8 inhibitory activity.

F. Rohdich, K. Georgi, A. Goutopoulos, 2021, ChemMedChem.

Centrality of drug targets in protein networks

A. Follis, A. Viacava Follis, 2021, BMC Bioinformatics.